Skip to main content
Clinical Trials/NCT04564677
NCT04564677
Recruiting
Not Applicable

A Prospective Study Evaluating the Clinical Outcome of a Modified d'Hoore Technique for Laparoscopic Ventral Mesh Rectopexy

Duomed1 site in 1 country150 target enrollmentStarted: February 8, 2021Last updated:

Overview

Phase
Not Applicable
Status
Recruiting
Sponsor
Duomed
Enrollment
150
Locations
1
Primary Endpoint
Procedural efficacy - Number of participants with (serious) adverse events

Overview

Brief Summary

The purpose of this observational study is to evaluate the clinical outcome of a modified d'Hoore technique for laparoscopic ventral mesh rectopexy in patients with primary rectal prolapse, rectocele and/or enterocele.The goal of the study will be achieved by reporting the peri- and postoperative complications ((serious) adverse events), recurrences and re-interventions. Pre-operative to postoperative changes in pain, functional outcome and quality of life will be evaluated as well.

Study Design

Study Type
Observational
Observational Model
Case Only
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Female patients.
  • Patient ≥ 18 years of age at study entry.
  • Patient and investigator signed and dated the informed consent form prior to the index-procedure.
  • Patient with primary rectal prolapse (grades I to V according to the Oxford scale), rectocele and/or enterocele.

Exclusion Criteria

  • Patient is unable / unwilling to provide informed consent.
  • Patient with recurrent rectal prolapse, rectocele and/or enterocele.
  • Patient is unable to comply with the study protocol or proposed follow-up visits.
  • Patient has a contra-indication for laparoscopic ventral mesh rectopexy.

Outcomes

Primary Outcomes

Procedural efficacy - Number of participants with (serious) adverse events

Time Frame: Follow-up 4: 36 months after the procedure

Number of participants with (serious) adverse events ≥ grade II Clavien-Dindo

Procedural efficacy - Number of re-interventions

Time Frame: Follow-up 4: 36 months after the procedure

Number of re-interventions

Procedural efficacy - Conversion rate to laparotomy during the index procedure

Time Frame: During procedure

Number of conversions to laparotomy during the index procedure

Procedural efficacy - Number of post-operative recurrences

Time Frame: Follow-up 4: 36 months after the procedure

Number of post-operative recurrences

Secondary Outcomes

  • Functional score - Obstructive Defecation Syndrome (ODS) score(Follow-up 4: 36 months after the procedure)
  • Post-operative abdominal pain by means of the Visual Analogue Scale (VAS)(Follow-up 4: 36 months after the procedure)
  • Pre-operative abdominal pain by means of the Visual Analogue Scale (VAS)(At baseline)
  • Functional score - Cleveland Clinical Incontinence Score (CCIS)(Follow-up 4: 36 months after the procedure)
  • Quality of life - Birmingham Bowel and Urinary Symptoms Questionnaire (BBUSQ)(Follow-up 4: 36 months after the procedure)
  • Pre-operative vaginal pain by means of the Visual Analogue Scale (VAS)(At baseline)
  • Post-operative vaginal pain by means of the Visual Analogue Scale (VAS)(Follow-up 4: 36 months after the procedure)

Investigators

Sponsor
Duomed
Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials